BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 25146483)

  • 1. Structural studies of virus-antibody immune complexes (poliovirus type I): Characterization of the epitopes in 3D.
    Bannwarth L; Girerd-Chambaz Y; Arteni AA; Guigner JM; Lemains J; Ronzon F; Manin C; Vénien-Bryan C
    Mol Immunol; 2015 Feb; 63(2):279-86. PubMed ID: 25146483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mapping of the epitopes of poliovirus type 2 in complex with antibodies.
    Bannwarth L; Girerd-Chambaz Y; Arteni A; Guigner JM; Ronzon F; Manin C; Vénien-Bryan C
    Mol Immunol; 2015 Oct; 67(2 Pt B):233-9. PubMed ID: 26059753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of antigenic profiles of inactivated poliovirus vaccine and vaccine-derived polioviruses by block-ELISA method.
    Rezapkin G; Martin J; Chumakov K
    Biologicals; 2005 Mar; 33(1):29-39. PubMed ID: 15713554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure of the complex between the Fab fragment of a neutralizing antibody for type 1 poliovirus and its viral epitope.
    Wien MW; Filman DJ; Stura EA; Guillot S; Delpeyroux F; Crainic R; Hogle JM
    Nat Struct Biol; 1995 Mar; 2(3):232-43. PubMed ID: 7539711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluorescence correlation spectroscopy as a sensitive and useful tool for revealing potential overlaps between the epitopes of monoclonal antibodies on viral particles.
    Richert L; Humbert N; Larquet E; Girerd-Chambaz Y; Manin C; Ronzon F; Mély Y
    MAbs; 2016 Oct; 8(7):1235-1244. PubMed ID: 27428887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mapping Antigenic Epitopes on the Human Bocavirus Capsid.
    Kailasan S; Garrison J; Ilyas M; Chipman P; McKenna R; Kantola K; Söderlund-Venermo M; Kučinskaitė-Kodzė I; Žvirblienė A; Agbandje-McKenna M
    J Virol; 2016 May; 90(9):4670-4680. PubMed ID: 26912619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoclonal antibodies reactive with different sites of N and H antigenic particles of poliovirus.
    Taniguchi K; Urasawa S; Urasawa T
    J Gen Virol; 1983 Dec; 64 ( Pt 12)():2803-8. PubMed ID: 6198442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flexibility of the major antigenic loop of foot-and-mouth disease virus bound to a Fab fragment of a neutralising antibody: structure and neutralisation.
    Verdaguer N; Schoehn G; Ochoa WF; Fita I; Brookes S; King A; Domingo E; Mateu MG; Stuart D; Hewat EA
    Virology; 1999 Mar; 255(2):260-8. PubMed ID: 10069951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Principal and subsidiary antigenic sites of VP1 involved in the neutralization of poliovirus type 3.
    Minor PD; Evans DM; Ferguson M; Schild GC; Westrop G; Almond JW
    J Gen Virol; 1985 May; 66 ( Pt 5)():1159-65. PubMed ID: 2582084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-Resolution Structure Analysis of Antibody V5 and U4 Conformational Epitopes on Human Papillomavirus 16.
    Guan J; Bywaters SM; Brendle SA; Ashley RE; Makhov AM; Conway JF; Christensen ND; Hafenstein S
    Viruses; 2017 Dec; 9(12):. PubMed ID: 29211035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Comprehensive Study of Neutralizing Antigenic Sites on the Hepatitis E Virus (HEV) Capsid by Constructing, Clustering, and Characterizing a Tool Box.
    Zhao M; Li XJ; Tang ZM; Yang F; Wang SL; Cai W; Zhang K; Xia NS; Zheng ZZ
    J Biol Chem; 2015 Aug; 290(32):19910-22. PubMed ID: 26085097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antigenic structure of polioviruses of serotypes 1, 2 and 3.
    Minor PD; Ferguson M; Evans DM; Almond JW; Icenogle JP
    J Gen Virol; 1986 Jul; 67 ( Pt 7)():1283-91. PubMed ID: 2425046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural Analysis of Der p 1-Antibody Complexes and Comparison with Complexes of Proteins or Peptides with Monoclonal Antibodies.
    Osinski T; Pomés A; Majorek KA; Glesner J; Offermann LR; Vailes LD; Chapman MD; Minor W; Chruszcz M
    J Immunol; 2015 Jul; 195(1):307-16. PubMed ID: 26026055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Minute virus of mice, a parvovirus, in complex with the Fab fragment of a neutralizing monoclonal antibody.
    Kaufmann B; López-Bueno A; Mateu MG; Chipman PR; Nelson CD; Parrish CR; Almendral JM; Rossmann MG
    J Virol; 2007 Sep; 81(18):9851-8. PubMed ID: 17626084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structurally Mapping Antigenic Epitopes of Adeno-associated Virus 9: Development of Antibody Escape Variants.
    Emmanuel SN; Smith JK; Hsi J; Tseng YS; Kaplan M; Mietzsch M; Chipman P; Asokan A; McKenna R; Agbandje-McKenna M
    J Virol; 2022 Feb; 96(3):e0125121. PubMed ID: 34757842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure of the complex of an Fab fragment of a neutralizing antibody with foot-and-mouth disease virus: positioning of a highly mobile antigenic loop.
    Hewat EA; Verdaguer N; Fita I; Blakemore W; Brookes S; King A; Newman J; Domingo E; Mateu MG; Stuart DI
    EMBO J; 1997 Apr; 16(7):1492-500. PubMed ID: 9130694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure determination of an Fab fragment that neutralizes human rhinovirus 14 and analysis of the Fab-virus complex.
    Liu H; Smith TJ; Lee WM; Mosser AG; Rueckert RR; Olson NH; Cheng RH; Baker TS
    J Mol Biol; 1994 Jul; 240(2):127-37. PubMed ID: 8027997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antigenic structure of poliovirus in inactivated vaccines.
    Ferguson M; Wood DJ; Minor PD
    J Gen Virol; 1993 Apr; 74 ( Pt 4)():685-90. PubMed ID: 7682250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antigenic sites of poliovirus type 3 eliciting IgA monoclonal antibodies in orally immunized mice.
    Buttinelli G; Ruggeri FM; Marturano J; Novello F; Donati V; Fiore L
    Virology; 2001 Mar; 281(2):265-71. PubMed ID: 11277698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of human monoclonal antibodies that neutralize multiple poliovirus serotypes.
    Puligedda RD; Kouiavskaia D; Al-Saleem FH; Kattala CD; Nabi U; Yaqoob H; Bhagavathula VS; Sharma R; Chumakov K; Dessain SK
    Vaccine; 2017 Oct; 35(41):5455-5462. PubMed ID: 28343771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.